TipRanks

Alex Azar Insider Profile

4 Followers
Alex Azar, Director at Guardant Health, holds 893.00 shares in Guardant Health (Ticker: GH), holds 5.01K shares in Eli Lilly & Co (Ticker: LLY), holds ― shares in Hms Holdings (Ticker: HMSY). Most recently, Alex Azar Sold ― shares of Guardant Health on Oct 15, 2026 for an estimated value of $11.03K.
tipranks
Alex Azar

Alex Azar
Guardant Health (GH)
Director

Ranked #49,181 out of 109,287 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+8.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
97.64%
2.36%
A breakdown of Alex Azar's holdings

Insider Roles

Eli Lilly & Co
(LLY)
Sr. VP, Corp. Affairs & Comm.
Guardant Health
(GH)
Director
Roles that Alex Azar holds in companies

Most Profitable Insider Trade

Stock:
Guardant Health
(GH)
Rating:Informative Sell
Date:Sep 17, 2026 - Today
Return:+13.30%
The most profitable trade made by Alex Azar

Alex Azar's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Guardant Health
Oct 15, 2026
Director
Informative Sell
11.03K
$154.71K
Eli Lilly & Co
―
Sr. VP, Corp. Affairs & Comm.
―
$6.41M
HMSY
Hms Holdings
Aug 22, 2017
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Alex Azar's performance on stock

Alex Azar insider profile FAQ

What is the percentage of profitable transactions made by Alex Azar?
The percentage of profitable transactions made by Alex Azar is 100%.
    What is the average return per transaction made by Alex Azar?
    The average return per transaction made by Alex Azar is 8.80%.
      What stocks does Alex Azar hold?
      Alex Azar holds: GH, LLY, HMSY stocks.
        What was Alex Azar’s latest transaction?
        Alex Azar latest transaction was an Informative Sell of $11.03K.
          What was Alex Azar's most profitable transaction?
          Alex Azar’s most profitable transaction was an Informative Sell of GH stock on September 17, 2026. The return on the trade was 13.30%.
            What is Alex Azar's role in Guardant Health?
            Alex Azar's role in Guardant Health is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.